- Home
- YHGJ vs ADGM Comparison
YHGJ vs ADGM Comparison
Compare YHGJ & ADGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YHGJ
- ADGM
- Stock Information
- Founded
- YHGJ 1975
- ADGM 2011
- Country
- YHGJ United States
- ADGM United States
- Employees
- YHGJ N/A
- ADGM N/A
- Industry
- YHGJ Specialty Chemicals
- ADGM
- Sector
- YHGJ Industrials
- ADGM
- Exchange
- YHGJ Nasdaq
- ADGM NYSE
- Market Cap
- YHGJ 15.8M
- ADGM 14.7M
- IPO Year
- YHGJ 1997
- ADGM N/A
- Fundamental
- Price
- YHGJ $1.05
- ADGM $0.74
- Analyst Decision
- YHGJ
- ADGM
- Analyst Count
- YHGJ 0
- ADGM 0
- Target Price
- YHGJ N/A
- ADGM N/A
- AVG Volume (30 Days)
- YHGJ 87.5K
- ADGM 38.6K
- Earning Date
- YHGJ 04-11-2025
- ADGM 03-31-2025
- Dividend Yield
- YHGJ N/A
- ADGM N/A
- EPS Growth
- YHGJ N/A
- ADGM N/A
- EPS
- YHGJ N/A
- ADGM N/A
- Revenue
- YHGJ $18,559,000.00
- ADGM $602,000.00
- Revenue This Year
- YHGJ N/A
- ADGM N/A
- Revenue Next Year
- YHGJ N/A
- ADGM N/A
- P/E Ratio
- YHGJ N/A
- ADGM N/A
- Revenue Growth
- YHGJ 11.78
- ADGM 100.67
- 52 Week Low
- YHGJ $0.43
- ADGM $0.70
- 52 Week High
- YHGJ $1.66
- ADGM $9.34
- Technical
- Relative Strength Index (RSI)
- YHGJ 59.63
- ADGM N/A
- Support Level
- YHGJ $0.91
- ADGM N/A
- Resistance Level
- YHGJ $0.69
- ADGM N/A
- Average True Range (ATR)
- YHGJ 0.10
- ADGM 0.00
- MACD
- YHGJ -0.02
- ADGM 0.00
- Stochastic Oscillator
- YHGJ 58.33
- ADGM 0.00
Stock Price Comparison Chart: YHGJ vs ADGM
About YHGJ Yunhong Green CTI Ltd.
Yunhong Green CTI Ltd manufactures and marketers of foil balloons and produces laminated and printed films for commercial uses. The company also distributes balloon-inspired and other gift items, and continues development of compostable material solutions, and markets its products throughout the United States and in several other countries.
About ADGM ADAGIO MEDICAL HOLDINGS INC
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.